Back to search

Peptide record

TPDB09816

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09816
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP Peptipedia Antifungipept CAFPdb
standard
No
A 21-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, Peptipedia, and other sources, with an available 3D structural model.
Sequence
GLLSGILGAGKHIVCGLSGLK
Physicochemical Analysis
C89H157N25O24S1
RNDEQMFPTWY
G
1993.44
9.90
3
0
9
+2
-0.50
1.024
148.57
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
3
Residue Composition
number
1
A
0
R
0
N
0
D
1
C
0
E
0
Q
6
G
1
H
2
I
5
L
2
K
0
M
0
F
0
P
2
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 1 E: 0 Q: 0 G: 6 H: 1 I: 2 L: 5 K: 2 M: 0 F: 0 P: 0 S: 2 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
21
C89H157N25O24S1
1993.44
9.90
+2
-0.50
1.024
Evidence Records 16 records
Evidence 1 Activity

Activity

MIC
Antibacterial
4.7 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml)
Evidence 2 Activity

Activity

MIC
Antibacterial
4.7 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml). Also histamine release. I
Evidence 3 Activity

Activity

MIC
Antibacterial
18.8 µg/mL

Target

B. subtilis

Source & Reference

dbAMP

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml). Also histamine release. It showed an effect on HIV when
Evidence 4 Activity

Activity

MIC
Antibacterial
1.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP

Other

nst E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml). Also histamine release. It showed an effect on HIV when applied in combination with OdK1
Evidence 5 Activity

Activity

MIC
Antifungal
4.7 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml)
Evidence 6 Activity

Activity

MIC
Antifungal
4.7 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP CAFPdb Antifungipept

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml). Also histamine release. I
Evidence 7 Activity

Activity

MIC
Antifungal
18.8 µg/mL

Target

B. subtilis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml). Also histamine release. It showed an effect on HIV when
Evidence 8 Activity

Activity

MIC
Antifungal
1.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP CAFPdb Antifungipept

Other

nst E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml). Also histamine release. It showed an effect on HIV when applied in combination with OdK1
Evidence 9 Activity

Activity

MIC
Antiparasitic
4.7 µg/mL

Target

Escherichia coli

Source & Reference

NA

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml)
Evidence 10 Activity

Activity

MIC
Antiparasitic
4.7 µg/mL

Target

Staphylococcus aureus

Source & Reference

NA

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml). Also histamine release. I
Evidence 11 Activity

Activity

MIC
Antiparasitic
18.8 µg/mL

Target

B. subtilis

Source & Reference

NA

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml). Also histamine release. It showed an effect on HIV when
Evidence 12 Activity

Activity

MIC
Antiparasitic
1.1 µg/mL

Target

Candida albicans

Source & Reference

NA

Other

nst E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml). Also histamine release. It showed an effect on HIV when applied in combination with OdK1
Evidence 13 Activity

Activity

MIC
Antiviral
4.7 µg/mL

Target

Escherichia coli

Source & Reference

NA

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml)
Evidence 14 Activity

Activity

MIC
Antiviral
4.7 µg/mL

Target

Staphylococcus aureus

Source & Reference

NA

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml). Also histamine release. I
Evidence 15 Activity

Activity

MIC
Antiviral
18.8 µg/mL

Target

B. subtilis

Source & Reference

NA

Other

active against E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml). Also histamine release. It showed an effect on HIV when
Evidence 16 Activity

Activity

MIC
Antiviral
1.1 µg/mL

Target

Candida albicans

Source & Reference

NA

Other

nst E. coli (MIC 4.7 ug/ml), S. aureus (MIC 4.7 ug/ml), B. subtilis (MIC 18.8 ug/ml), and C. albicans (MIC 1.1 ug/ml). Also histamine release. It showed an effect on HIV when applied in combination with OdK1